Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalya M Kogan

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Mini Reviews in Medicinal Chemistry|October 28, 2005
Cannabinoids and cancerNatalya M Kogan
Expert Opinion on Investigational Drugs|August 24, 2007
HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicityMaximilian Peters, Natalya M Kogan
Dialogues in Clinical Neuroscience|February 22, 2008
Cannabinoids in health and diseaseNatalya M Kogan, Raphael Mechoulam
Stem Cells (Dayton, Ohio)|April 16, 2015
Concise Review: Energy Metabolites: Key Mediators of the Epigenetic State of PluripotencyArieh Moussaieff, Natalya M Kogan, Daniel Aberdam
Annual Review of Pharmacology and Toxicology|October 4, 2019
Beyond THC and EndocannabinoidsPal Pacher, Natalya M Kogan, Raphael Mechoulam
Molecules (Basel, Switzerland)|April 3, 2021
Cannabinoid Quinones-A Review and Novel ObservationsNatalya M Kogan, Maximilian Peters, Raphael Mechoulam
Pharmaceutics|January 23, 2024
Targeted Glioma Therapy-Clinical Trials and Future DirectionsAleksandr Shikalov, Igor Koman, Natalya M Kogan
The Journal of Pharmacology and Experimental Therapeutics|May 5, 2007
A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo studyNatalya M Kogan, Michael Schlesinger, Maximilian Peters, et al.
Frontiers in Immunology|July 2, 2025
Differential metabolic pathways underlie THC- and CBD-mediated inhibition of B-cell activation in both young and aged miceZhanna Yekhtin, Dmytro Petukhov, Iman Khuja, et al.
Journal of Medicinal Chemistry|July 9, 2004
Synthesis and antitumor activity of quinonoid derivatives of cannabinoidsNatalya M Kogan, Ruth Rabinowitz, Paloma Levi, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Mini Reviews in Medicinal Chemistry|October 28, 2005
Cannabinoids and cancerNatalya M Kogan
Expert Opinion on Investigational Drugs|August 24, 2007
HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicityMaximilian Peters, Natalya M Kogan
Dialogues in Clinical Neuroscience|February 22, 2008
Cannabinoids in health and diseaseNatalya M Kogan, Raphael Mechoulam
Stem Cells (Dayton, Ohio)|April 16, 2015
Concise Review: Energy Metabolites: Key Mediators of the Epigenetic State of PluripotencyArieh Moussaieff, Natalya M Kogan, Daniel Aberdam
Annual Review of Pharmacology and Toxicology|October 4, 2019
Beyond THC and EndocannabinoidsPal Pacher, Natalya M Kogan, Raphael Mechoulam
Molecules (Basel, Switzerland)|April 3, 2021
Cannabinoid Quinones-A Review and Novel ObservationsNatalya M Kogan, Maximilian Peters, Raphael Mechoulam
Pharmaceutics|January 23, 2024
Targeted Glioma Therapy-Clinical Trials and Future DirectionsAleksandr Shikalov, Igor Koman, Natalya M Kogan
The Journal of Pharmacology and Experimental Therapeutics|May 5, 2007
A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo studyNatalya M Kogan, Michael Schlesinger, Maximilian Peters, et al.
Frontiers in Immunology|July 2, 2025
Differential metabolic pathways underlie THC- and CBD-mediated inhibition of B-cell activation in both young and aged miceZhanna Yekhtin, Dmytro Petukhov, Iman Khuja, et al.
Journal of Medicinal Chemistry|July 9, 2004
Synthesis and antitumor activity of quinonoid derivatives of cannabinoidsNatalya M Kogan, Ruth Rabinowitz, Paloma Levi, et al.
Pageof 3